A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions
Clinical trial NCT03843541 · COMPLETED
Trial details
- NCT number
- NCT03843541
- Sponsor
- Zambon SpA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2021-01-23
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.